6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
2h ago	Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026
12h ago	Pony.ai Announces New Generation Autonomous Driving Compute Platform Built on NVIDIA DRIVE Hyperion
20h ago	IFS announces filing of 2025 Annual Report on Form 20-F
20h ago	Related Digital Announces Financing for $16 Billion Oracle Data Center Project in Saline Township, Michigan
20h ago	Questerre Energy Corporation Issues Clarification to Press Release from April 24, 2026

About

Eton Pharmaceuticals Inc (NASDAQ:ETON) — investor relations, events, news, and company updates on 6ix.

Latest News

Eton Pharmaceuticals Announces CFO Succession Plan

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

Financials

Revenue

$79.95 M

Market Cap

$682.11 M

EPS

-0.17

Community Chat

Ask AI